Key statistics
On Friday, Regenxbio Inc (RB0:FRA) closed at 6.95, 48.50% above the 52 week low of 4.68 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 6.95 |
|---|---|
| High | 6.95 |
| Low | 6.95 |
| Bid | 6.55 |
| Offer | 6.85 |
| Previous close | 7.10 |
| Average volume | 1.95k |
|---|---|
| Shares outstanding | 50.62m |
| Free float | 46.57m |
| P/E (TTM) | -- |
| Market cap | 404.48m USD |
| EPS (TTM) | -3.46 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 07:00 GMT.
More ▼
Press releases
- REGENXBIO Announces Regulatory Update on RGX-121 BLA for MPS II
- Investigation into Regenxbio: Questions Arise Over Disclosure Completeness Prior to FDA Action
- REGENXBIO Announces Regulatory Update on Ultra Rare MPS Programs
- REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program
- REGENXBIO to Present at the 44th Annual J.P. Morgan Healthcare Conference
- REGENXBIO to Participate in Upcoming Investor Conference
More ▼
